Rochelle Seide
Corporate Officer/Principal en Biovail Laboratories International SRL .
Origen de la red de primer grado Rochelle Seide.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Biovail Laboratories International SRL
 Biovail Laboratories International SRL Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Biovail Laboratories International SRL develops, manufactures, and sells pharmaceutical products. The company is based in Saint Michael, Barbados.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Rochelle Seide a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Biovail Pharmaceuticals LLC
 Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of British Columbia | College/University | Corporate Officer/Principal | |
| University of Manitoba | College/University | Undergraduate Degree | |
AiVita Biomedical, Inc.
 AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
GABA Therapeutics, Inc.
 GABA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gaba Therapeutics, Inc. is biotechnology company. It develops its compound GRX-917 for anxiety, depression and a broad range of neurological disorders. The company is headquartered in Newport Beach, CA. | Pharmaceuticals: Major | Director/Board Member | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOASIS TECHNOLOGIES INC. | Biotechnology | Director/Board Member | |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Princeton University | College/University | Doctorate Degree | |
| University of Victoria | College/University | Undergraduate Degree | |
| University of Oxford | College/University | Graduate Degree |
Estadísticas
Internacional
| Canadá | 12 |
| Estados Unidos | 8 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 15 |
| Consumer Services | 6 |
Operativa
| Director/Board Member | 9 |
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 2 |
| Chief Operating Officer | 1 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Rochelle Seide
- Conexiones Empresas
